TXO Partners LP (TXO)
(Real Time Quote from BATS)
$20.07 USD
+0.07 (0.35%)
Updated Jun 28, 2024 02:24 PM ET
4-Sell of 5 4
B Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for TXO Partners LP falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 381 | 246 | 228 | 109 | NA |
Cost Of Goods | 145 | 128 | 69 | 49 | NA |
Gross Profit | 236 | 118 | 159 | 60 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 360 | 144 | 115 | 215 | 0 |
Income After Depreciation & Amortization | -124 | -26 | 44 | -155 | 0 |
Non-Operating Income | 24 | 26 | 14 | 0 | NA |
Interest Expense | 4 | 8 | 6 | 8 | NA |
Pretax Income | -104 | -8 | 52 | -163 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -104 | -8 | 52 | -163 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -104 | -8 | 52 | -163 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 144 | 16 | 84 | 21 | 0 |
Depreciation & Amortization (Cash Flow) | 268 | 41 | 40 | 176 | NA |
Income After Depreciation & Amortization | -124 | -26 | 44 | -155 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 30.27 | 30.75 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | 1.34 | -0.25 | NA | NA | NA |
Diluted Net EPS (GAAP) | -3.44 | -0.25 | NA | NA | NA |
Fiscal Year end for TXO Partners LP falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 67.44 | 91.97 | 69.87 | 60.47 | 158.40 |
Cost Of Goods | 33.21 | 34.44 | 35.68 | 39.37 | 35.39 |
Gross Profit | 34.23 | 57.54 | 34.19 | 21.10 | 123.01 |
SG&A, R&D, and Dept/Amort Expenses | 31.53 | 255.75 | 29.82 | 29.87 | 44.18 |
Income After SG&A, R&D, and Dept/Amort Expenses | 2.70 | -198.21 | 4.37 | -8.77 | 78.83 |
Non-Operating Income | 8.54 | 5.64 | 5.31 | 6.85 | 6.42 |
Interest Expense | 0.98 | 1.16 | 1.20 | 0.62 | 1.44 |
Pretax Income | 10.27 | -193.73 | 8.48 | -2.55 | 83.81 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 10.27 | -193.73 | 8.48 | -2.55 | 83.81 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 10.27 | -193.73 | 8.48 | -2.55 | 83.81 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 31.43 | 30.41 | 31.29 | 30.75 | 29.33 |
Diluted EPS Before Non-Recurring Items | 0.33 | 0.98 | 0.27 | -0.08 | 0.29 |
Diluted Net EPS (GAAP) | 0.33 | -6.49 | 0.27 | -0.08 | 2.86 |